Clinical trials
on Alexander disease

Safety and efficacy of Zilganersen – Interventional – NCT04849741
Evaluating the safety and efficacy of Zilganersen, an antisense oligonucleotide targeting GFAP production
Clinicaltrial.gov Ionis website
AxD Outcomes – Observational – NCT02714764
Study on the natural history of Alexander disease
Clinicaltrial.gov Children’s Hospital of Philadelphia website